about
The Relationship between Dyslipidemia and Acute Axonal Function in Type 2 Diabetes Mellitus In VivoRisk of recurrence, subsequent mode of birth and morbidity for women who experienced severe perineal trauma in a first birth in New South Wales between 2000-2008: a population based data linkage study.Trends and risk factors for severe perineal trauma during childbirth in New South Wales between 2000 and 2008: a population-based data study.Rates of obstetric intervention and associated perinatal mortality and morbidity among low-risk women giving birth in private and public hospitals in NSW (2000-2008): a linked data population-based cohort study.Generalisability of pharmacoepidemiological studies using restricted prescription data.Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial.Intravesical chemotherapy plus bacille Calmette-Guérin in non-muscle invasive bladder cancer: a systematic review with meta-analysis.Impact of EGFR inhibitor in non-small cell lung cancer on progression-free and overall survival: a meta-analysis.Treatment strategies and survival of older breast cancer patients - an international comparison between the Netherlands and IrelandCarboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer.Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer.CA-125 can be part of the tumour evaluation criteria in ovarian cancer trials: experience of the GCIG CALYPSO trialFinal overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients.Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma.Rates of obstetric intervention among low-risk women giving birth in private and public hospitals in NSW: a population-based descriptive studyMarkers of systemic inflammation predict survival in patients with advanced renal cell cancer.End-of-life prescribing of aspirin in patients with breast or colorectal cancer.Comorbidity, age of onset and suicidality in obsessive-compulsive disorder (OCD): An international collaboration.De Novo Post-Diagnosis Aspirin Use and Mortality in Women with Stage I-III Breast Cancer.Patterns of care in adult medulloblastoma: results of an international online survey.Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study.Phase 2 trial of temozolomide and pegylated liposomal doxorubicin in the treatment of patients with glioblastoma multiforme following concurrent radiotherapy and chemotherapy.Health-related quality of life in recurrent platinum-sensitive ovarian cancer--results from the CALYPSO trial.Can pelvic floor trauma be predicted antenatally?Changes in maternal abdominal subcutaneous fat layers using ultrasound: A longitudinal study.The Nepean Belief Scale: preliminary reliability and validity in obsessive-compulsive disorder.A phase II clinical trial of the vascular disrupting agent BNC105P as second line chemotherapy for advanced Malignant Pleural Mesothelioma.Lung cancer clinicians' preferences for adjuvant chemotherapy in non-small-cell lung cancer: what makes it worthwhile?Radiotherapy for anal squamous cell carcinoma: must the upper pelvic nodes and the inguinal nodes be treated?Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study.Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial.Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomasA prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancerEarly Decline in Cancer Antigen 125 as a Surrogate for Progression-Free Survival in Recurrent Ovarian CancerPopulation case-control study of cerebral palsy: neonatal predictors for low-risk term singletonsLong-term fenofibrate therapy increases fibroblast growth factor 21 and retinol-binding protein 4 in subjects with type 2 diabetesSmoking at diagnosis is an independent prognostic factor for cancer-specific survival in head and neck cancer: findings from a large, population-based studyRelationships between supportive care needs and perceived burden in breast cancer survivor-caregiver dyadsOutcomes for elderly patients 75 years and older treated with curative intent radiotherapy for mucosal squamous cell carcinomas of the head and neckPattern of failure in anaplastic glioma patients with an IDH1/2 mutation
P50
Q28551366-1D502886-499A-4B19-A6C0-1046929B3A62Q30613306-BBF92865-ECF6-4EEB-A378-C7D9D5D4012AQ30651152-C7F22029-D3DE-4923-A08C-97D18E564730Q30825096-FD50B1DD-A981-47B4-A4DE-AF9FAC4F8DDEQ31002462-1A58FCDC-A966-4812-B8BE-3C3E7463EF48Q33419460-1A982277-0D6F-43FA-8B0F-0A65F56DDBA2Q34318570-D248C8DA-F6D0-4DC0-B960-23A51891284FQ34339890-A8BC6C75-CCA9-484A-AD49-EEB4DDEB1B5AQ35043918-46632117-EE7A-4C9E-ADE6-2E87EF8B70AAQ35212672-9455C812-9054-4E09-A3CC-CEBAD9D2A170Q35527133-244D3D8B-7F19-4A44-8B21-38776662D087Q35879853-AAD1C67B-766A-49A5-9E8B-BB1BB1D70AF1Q36166812-9D28543E-BCF3-4885-85FE-917E4896004BQ36288280-9C273E61-661E-45D2-9404-924AE960E8F4Q36307000-44F9C51B-EBDA-49B3-A20C-81A6FBB8D996Q37003374-A18EC182-E71E-4185-B5EC-0464AB251AADQ38609507-18988AE0-4FE6-47D3-BA80-BC33553CD4D9Q38824774-4B2D1710-C993-48F9-A75A-65FA94602EEBQ39027247-E0EDFFFD-6A6A-4131-80FA-D5A2C3689C8AQ39159565-7258262B-E78D-4E04-A419-C3FC9905D1DDQ42706819-7C977620-BDAC-4CBA-893A-6438006D9DC2Q43464631-8491AA5D-9C3C-4499-A8CD-7AA5A5E85344Q48489815-D4701F96-AA7C-4CDB-94D0-B87AE5F0832FQ49378535-0B40109C-30BD-4762-B64B-9D2EBB4F4272Q50165870-298307FE-5E1D-4353-8116-57FCC820A45EQ50199988-F7F7DF6C-7369-4E35-99DA-12E5D39D6D43Q50798185-53B786C5-8724-4FDE-BEE7-F47A77DB6135Q51543821-9305042A-73B7-41A4-BD38-1213A1FF0FC2Q52669041-33D5C840-E4B1-4D1F-B70D-362D3569E18AQ53045551-9E8B9E21-A75C-4DB4-8A39-4E69E5F5AAC6Q53144473-D2B7F5FB-6B04-4C52-B4F9-721E1221DACBQ60685884-07A3BF4A-40F4-450E-A4B9-A69DCC119658Q61441066-5F937FEC-077C-484E-B1A5-21A459C83181Q61441068-5394B6E1-373F-4F67-9ACE-B0143F34E627Q83456621-85E9B25F-562C-4ABC-B95A-0B0A52DA756EQ85412251-00833F5A-990D-46C6-B00D-851242117BA9Q87589669-1C63DB82-6958-4082-A25A-F6E646794533Q90278737-D19C411C-BD40-4908-9E2C-B594CC4C0154Q90588726-0A1498BD-9F96-413A-88FB-DB61B9173DD3Q91558162-4B6AA809-162B-4817-9290-DB8C50024B1C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Chris Brown
@ast
Chris Brown
@en
Chris Brown
@es
Chris Brown
@nl
Chris Brown
@sl
ক্রিস ব্রাউন
@bn
type
label
Chris Brown
@ast
Chris Brown
@en
Chris Brown
@es
Chris Brown
@nl
Chris Brown
@sl
ক্রিস ব্রাউন
@bn
prefLabel
Chris Brown
@ast
Chris Brown
@en
Chris Brown
@es
Chris Brown
@nl
Chris Brown
@sl
ক্রিস ব্রাউন
@bn
P106
P1153
55496749500
P31
P496
0000-0003-2506-4871